50 / 210
XXXII Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia
50
14. Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET)
impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol
2012;32:1777-83.
15. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S,
Goosmann C, et al. Reciprocal coupling of coagulation and inna-
te immunity via neutrophil serine proteases. Nat Med 2010;16:
887-96.
16. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I,
et al. Oxidation of a specific methionine in thrombomodulin by
activated neutrophil products blocks cofactor activity. A poten-
tial rapid mechanism for modulation of coagulation. J Clin Invest
1992;90:2565-73.
17. Jiménez-Alcázar M, Napirei M, Panda R, Kohler EC, Kremer Hovin-
ga JA, Mannherz HG, et al. Impaired DNase1-mediated degradation
of neutrophil extracellular traps is associated with acute thrombotic
microangiopathies. J Thromb Haemost 2015;13:732-42.
18. HakkimA, Furnrohr BG,Amann K, Laube B,Abed UA, BrinkmannV,
et al. Impairment of neutrophil extracellular trap degradation is associa-
ted with lupus nephritis. Proc Natl Acad Sci U SA 2010;107:9813-8.
19. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F,
et al. Extracellular histones are major mediators of death in sepsis.
Nat Med 2009;15:1318-21.
20. Demers M, Wagner DD. NETosis: a new factor in tumor progres-
sion and cancer-associated thrombosis. Semin Thromb Hemost
2014;40:277-83.
21. Van Montfoort ML, Stephan F, Lauw MN, Hutten BA, Van Mierlo
GJ, Solati S, et al. Circulating nucleosomes and neutrophil activation
as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc
Biol 2013;33:147-51.
22. Díaz JA, Fuchs TA, Jackson TO, Kremer Hovinga JA, Lammle B,
Henke PK, et al. Plasma DNA is Elevated in Patients with DeepVein
Thrombosis. J Vasc Surg Venous Lymphat Disord 2013;1:341-8.